- Home
- INVA vs QQQX Comparison
INVA vs QQQX Comparison
Compare INVA & QQQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INVA | QQQX |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | INVA | QQQX |
|---|---|---|
| Price | $19.00 | $29.22 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $34.80 | N/A |
| AVG Volume (30 Days) | ★ 766.7K | 96.5K |
| Earning Date | 11-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.03% |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $9.72 | N/A |
| Revenue Next Year | $8.58 | N/A |
| P/E Ratio | $47.31 | ★ N/A |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $18.66 | $25.35 |
| 52 Week High | $25.15 | $31.87 |
Technical Indicators
Market Signals| Indicator | INVA | QQQX |
|---|---|---|
| Relative Strength Index (RSI) | 32.75 | 42.11 |
| Support Level | N/A | $28.48 |
| Resistance Level | $21.69 | $31.03 |
| Average True Range (ATR) | 0.68 | 0.61 |
| MACD | -0.21 | -0.06 |
| Stochastic Oscillator | 11.71 | 30.00 |
Price Performance
Historical ComparisonAbout INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets (as defined below) in a diversified equity portfolio made up of securities comprising the S&P 500 Index (or securities that have economic characteristics that are similar to those securities comprising the S&P 500 Index) that seeks to substantially replicate price movements of the S&P 500 Index and is designed to support the Fund's option strategy.